The precision diagnostics market in North America is expected to grow from US$ 33,625.95 million in 2022 to US$ 71,825.04 million by 2028. It is estimated to grow at a CAGR of 13.5% from 2022 to 2028.
The precision medicine concept is being applied robustly in caring for rare diseases. Although it is more prevalent in oncology, it is gradually spreading to other specialties. The rising prevalence of cancer and the growing incidence of rare neurological disorders are increasing the demand for precision medicine, which is driving the growth of the precision diagnostics market. In addition, the rising demand for treatment procedures in oncology and other disorders is surging the adoption of treatment procedures. The genetic test is useful in many areas of medicine as it identifies mutations or variants in the DNA. Genetic testing, for example, provides information about the risk of developing cancer and diagnose genetic conditions, such as Fragile X syndrome or Huntington's disease.
Based on the cancer type, genomic cancer testing helps to create more personalize cancer treatment and care plans by helping patients and doctors better understand the diagnosis and reveal specific cancer drivers and market players encourage genomic cancer testing from the beginning of a diagnosis so precision medicine can be administered earlier in the treatment procedure. Thus, early diagnosis can help to promote early and optimal management of the disorders.
Moreover, the growing number of strategic collaborations between biopharmaceutical companies to develop medicines targeted at treating a specific group of patients based on their particular requirements is increasing the number of clinical trials. The need to provide effective treatment procedures and services is also aiding the rise of clinical trials. For instance, Personal Genome Diagnostics Inc. and Massachusetts General Hospital collaborated to advance the development of effective treatment services in 2021. In April 2022, the Precision Cancer Consortium (PCC) was formed as a new collaboration of pharmaceutical companies with a shared vision of providing comprehensive testing to all cancer patients. The consortium aims to increase patient access to precision diagnostics using comprehensive genomic testing. The factors mentioned above are driving the precision diagnostics market substantially.
North America Precision Diagnostics Market Segmentation
The North America precision diagnostics market is segmented by type, application, end user, and country. Based on type, the market is segmented into genetic tests, esoteric tests, and others. The genetic tests segment dominated the market in 2022.
Based on application, the market is fragmented into oncology, cardiology, immunology, respiratory diseases, and others. The oncology segment dominated the market in 2022. Based on end user, the market is segmented into hospitals, clinical laboratories, home care, and others. The clinical laboratories segment dominated the market in 2022.
Based on country, the market is segmented into he US, Canada, and Mexico. Further, the US dominated the market in 2022.
A few key players dominating the North America precision diagnostics market are Abbott; Bayer AG; Koninklijke Philips N.V.; Lantheus Medical Imaging, Inc.; Novartis AG; QIAGEN; Quest Diagnostics Inc.; Sanofi; Siemens Healthineers AG; and Swiss Precision Diagnostics GmbH.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 33,625.95 Million |
| Market Size by 2028 | US$ 71,825.04 Million |
| CAGR (2022 - 2028) | 13.5% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
The North America Precision Diagnostics Market is valued at US$ 33,625.95 Million in 2022, it is projected to reach US$ 71,825.04 Million by 2028.
As per our report North America Precision Diagnostics Market, the market size is valued at US$ 33,625.95 Million in 2022, projecting it to reach US$ 71,825.04 Million by 2028. This translates to a CAGR of approximately 13.5% during the forecast period.
The North America Precision Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Precision Diagnostics Market report:
The North America Precision Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Precision Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Precision Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Precision Diagnostics Market
